Public Profile

Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc., headquartered in the United States, is a pioneering biopharmaceutical company focused on developing innovative therapies for rare diseases and unmet medical needs. Founded in 2020, Zevra has quickly established itself in the biotechnology industry, particularly in the areas of neurology and rare genetic disorders. The company’s core offerings include unique therapeutic solutions that leverage advanced scientific research and technology, setting them apart in a competitive market. Zevra's commitment to addressing complex health challenges has led to significant milestones, including the advancement of its lead product candidates through various stages of clinical development. With a strong emphasis on patient-centric approaches, Zevra Therapeutics is poised to make a meaningful impact in the lives of those affected by rare conditions.

DitchCarbon Score

How does Zevra Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Zevra Therapeutics, Inc.'s score of 13 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.

35%

Zevra Therapeutics, Inc.'s reported carbon emissions

Zevra Therapeutics, Inc., headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been reported. Consequently, there are no defined reduction targets or climate commitments outlined by the company at this time. In the absence of concrete emissions data, it is essential to note that many companies in the biopharmaceutical sector are increasingly focusing on sustainability and climate action. This includes setting science-based targets and committing to reducing their carbon footprints across various scopes of emissions. Zevra Therapeutics may align with industry trends by exploring future initiatives aimed at minimising their environmental impact, although specific commitments or targets have not been disclosed. As the company progresses, stakeholders will likely look for updates on their climate strategies and any potential emissions data in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Zevra Therapeutics, Inc.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Zevra Therapeutics, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Zevra Therapeutics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

Novartis

CH
Chemicals nec
Updated 1 day ago

DMK Pharmaceuticals Corporation

US
Chemicals nec
Updated 19 days ago

Cumberland Pharmaceuticals Inc.

US
Chemicals nec
Updated 12 days ago

Takeda

JP
Medical, precision and optical instruments, watches and clocks (33)
Updated about 6 hours ago

Janssen

US
Health and social work services (85)
Updated about 1 month ago

Alora Pharmaceuticals, LLC

US
Chemicals nec
Updated 19 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers